![Yumi Matsuzaki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Yumi Matsuzaki
Sociétés | Poste | Début | Fin |
---|---|---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Yumi Matsuzaki
Statistiques
Internationale
Japon | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
PuREC KK
![]() PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Health Technology |
- Bourse
- Insiders
- Yumi Matsuzaki
- Expérience